Cytokine therapies have the potential to transform cancer treatment by enhancing the body’s immune response to fight cancer ...
New data from the Phase 2 OVATION 2 study highlights potential improvements in survival outcomes with IMUNON's IMNN-001 for ...
Comprehensive Genomic Profiling (CGP) is reshaping cancer treatment by enabling precision oncology at an unprecedented scale.
This novel DNA plasmid vaccine targets antigen-presenting cells and aims to induce a robust immune response. Prof. Lindy ...
Promises of Innovation, Speed, and Savings,’ the latest research report by S&P Global Ratings. In a special session, we’ll ...
Antibody-drug conjugates (ADCs) represent a significant breakthrough in oncology, offering targeted treatments, especially for lung cancer. In this insightful interview with Dr. Nicolas Girard, Head ...
Antibody-Drug Conjugates (ADCs) are at the forefront of cancer treatment, providing targeted therapies with promising results for lung cancer. In this exclusive interview, we spoke with Dr. Maria de ...
The U.S. Food and Drug Administration (FDA) has approved Thermo Fisher’s Oncomine Dx Target Test, a next-generation sequencing (NGS)-based companion diagnostic, to identify patients eligible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback